Water → (+/-)-cis-1-[3,5-bis(trifluoromethyl)benzoyl]-4-[[3-(2-furanylmethyl)-3H-imidazo-[4,5-b]pyridin-2-yl]amino]-2-(phenylmethyl)piperidine
反応式
[F:1][C:2]([F:30])([F:29])[C:3]1[CH:4]=[C:5]([CH:22]=[C:23]([C:25]([F:28])([F:27])[F:26])[CH:24]=1)[C:6]([N:8]1[CH2:13][CH2:12][C:11](=O)[CH2:10][CH:9]1[CH2:15][C:16]1[CH:21]=[CH:20][CH:19]=[CH:18][CH:17]=1)=[O:7].[O:31]1[CH:35]=[CH:34][CH:33]=[C:32]1[CH2:36][N:37]1[C:41]2=[N:42][CH:43]=[CH:44][CH:45]=[C:40]2[N:39]=[C:38]1[NH2:46].C([BH3-])#N.[Na+].O>C(Cl)Cl.C(O)C.CC(C)[O-].[Ti+4].CC(C)[O-].CC(C)[O-].CC(C)[O-]>[F:26][C:25]([F:28])([F:27])[C:23]1[CH:22]=[C:5]([CH:4]=[C:3]([C:2]([F:30])([F:1])[F:29])[CH:24]=1)[C:6]([N:8]1[CH2:13][CH2:12][C@H:11]([NH:46][C:38]2[N:37]([CH2:36][C:32]3[O:31][CH:35]=[CH:34][CH:33]=3)[C:41]3=[N:42][CH:43]=[CH:44][CH:45]=[C:40]3[N:39]=2)[CH2:10][C@@H:9]1[CH2:15][C:16]1[CH:17]=[CH:18][CH:19]=[CH:20][CH:21]=1)=[O:7].[F:26][C:25]([F:28])([F:27])[C:23]1[CH:22]=[C:5]([CH:4]=[C:3]([C:2]([F:30])([F:1])[F:29])[CH:24]=1)[C:6]([N:8]1[CH2:13][CH2:12][C@@H:11]([NH:46][C:38]2[N:37]([CH2:36][C:32]3[O:31][CH:35]=[CH:34][CH:33]=3)[C:41]3=[N:42][CH:43]=[CH:44][CH:45]=[C:40]3[N:39]=2)[CH2:10][C@@H:9]1[CH2:15][C:16]1[CH:17]=[CH:18][CH:19]=[CH:20][CH:21]=1)=[O:7]参加物
反応物 4
生成物 2
試薬・触媒・溶媒 3
実験手順
A mixture of (±)-1-[3,5-bis(trifluoromethyl)benzoyl]-2-(phenylmethyl)-4-piperidinone (4.29 g), 3-(2-furanylmethyl)-3H-imidazo[4,5-b]pyridin-2-amine (2.14 g) and titanium(IV)isopropoxide (3.41 g) in CH2Cl2 (5 ml) was stirred at RT for 3 hours. A mixture of sodium cyanoborohydride (0.628 g) in ethanol (5 ml) was added. The mixture was stirred at RT overnight. Water (5 ml) and CH2Cl2 (300 ml) were added. The mixture was stirred for 15 minutes. The biphasic mixture was dried, filtered and the filtrate was evaporated. The residue was purified by HPLC (eluent: 0.5% NH4OC(O)CH3 /CH3CN 40/60). Two desired fractions were collected and their solvent was evaporated. Each residue was dried and ground, yielding 1.22 g (19.4%) of (±)-cis-1-[3,5-bis(trifluoromethyl)benzoyl]-4-[[3-(2-furanylmethyl)-3H-imidazo-[4,5-b]pyridin-2-yl]amino]-2-(phenylmethyl)piperidine (comp. 112; mp. 108.7° C.) and 0.14 g (2.2%) of (±)-trans-1-[3,5-bis(trifluoromethyl)benzoyl]-4-[[3-(2-furanylmethyl)-3H-imidazo[4,5-b]pyridin-2-yl]amino]-2-(phenylmethyl)piperidine (comp. 113; mp. 108.3° C.).
後処理
- additionwas added
- stirringThe mixture was stirred at RT overnight
- stirringThe mixture was stirred for 15 minutes
- customThe biphasic mixture was dried
- filtrationfiltered
- customthe filtrate was evaporated
- customThe residue was purified by HPLC (eluent: 0.5% NH4OC(O)CH3 /CH3CN 40/60)
- customTwo desired fractions were collected
- customtheir solvent was evaporated
- customEach residue was dried
出典と根拠
- ORDレコード
- ord-e6a0717aba724ebcb34fb76e398ac729
- 出典データセット
- uspto-grants-2000_08
- 特許番号
- US06110939
反応ノート
読み込み中…